Akshay Nanduri is CEO of Onc.AI. Previously, he was Founder/VP Strategy-BD at RefleXion (disruptive cancer treatment system that has raised $260M in VC financing and treating patients today) and Director of Software and early employee at SlipStream (acquired by BlackBerry). He holds an MBA from MIT Sloan and received his MASc/BASc from UWaterloo.
11:00 AM - 12:00 PM (PDT)
Tuesday, June 14
Life sciences and healthcare companies are leveraging machine learning and AI for new advancements…